CR1 and CR2: Receptors Mediating Cellular Recognition in the Complement System

作者: Douglas T. Fearon , Robert H. Carter , Joseph M. Ahearn

DOI: 10.1016/B978-0-12-150401-4.50006-7

关键词:

摘要: Publisher Summary The complement system is a mechanism for the recognition of microorganisms that proceeds through two phases, first being covalent attachment proteins—C3 and C4—to other proteins to carbohydrates are part complement-activating complex, second phase receptor-mediated binding these complexes by various cell types, such as lymphocytes phagocytes. Activation C4 proteolytic enzyme, C1s, releases C4a peptide from α-chain, inducing major conformational alteration C4b fragment exposes or catalyzes transacylation reaction involving an internal thiolester in α-polypeptide. Attachment C3b after activation C3 convertases either pathway occurs same mechanism: release C3a α-polypeptide C3, causing change activates thiol ester induces —OH groups. containing covalently bound fragments cells having receptors specific fragments. This chapter explains structure/function relationships CR1 CR2 presents novel approach antiinflammatory therapy employs recombinant soluble form CR1. It also discusses relationship between natural ligand-binding site Epstein–Barr virus.

参考文章(112)
V. M. Holers, D. D. Chaplin, J. F. Leykam, B. A. Gruner, V. Kumar, J. P. Atkinson, Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 2459- 2463 ,(1987) , 10.1073/PNAS.84.8.2459
Steven P. Leytus, Kotoku Kurachi, Kjell S. Sakariassen, Earl W. Davie, Nucleotide sequence of the cDNA coding for human complement C1r. Biochemistry. ,vol. 25, pp. 4855- 4863 ,(1986) , 10.1021/BI00365A020
Akitada Ichinose, Brad A. McMullen, Kazuo Fujikawa, Earl W. Davie, Amino acid sequence of the b subunit of human factor XIII, a protein composed of ten repetitive segments. Biochemistry. ,vol. 25, pp. 4633- 4638 ,(1986) , 10.1021/BI00364A027
H. Weisman, T Bartow, M. Leppo, H. Marsh, G. Carson, M. Concino, M. Boyle, K. Roux, M. Weisfeldt, D. Fearon, Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis Science. ,vol. 249, pp. 146- 151 ,(1990) , 10.1126/SCIENCE.2371562
J. M. Ahearn, S. D. Hayward, J. C. Hickey, D. T. Fearon, Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor Proceedings of the National Academy of Sciences of the United States of America. ,vol. 85, pp. 9307- 9311 ,(1988) , 10.1073/PNAS.85.23.9307
Linda K. Clayton, Monica Sieh, Donald A. Pious, Ellis L. Reinherz, Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding Nature. ,vol. 339, pp. 548- 551 ,(1989) , 10.1038/339548A0
L B Klickstein, W W Wong, J A Smith, J H Weis, J G Wilson, D T Fearon, Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins. Journal of Experimental Medicine. ,vol. 165, pp. 1095- 1112 ,(1987) , 10.1084/JEM.165.4.1095
Fritz Melchers, Anna Erdei, Thomas Schulz, Manfred P. Dierich, Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature. ,vol. 317, pp. 264- 267 ,(1985) , 10.1038/317264A0
J A Gelfand, M Donelan, A Hawiger, J F Burke, Alternative complement pathway activation increases mortality in a model of burn injury in mice. Journal of Clinical Investigation. ,vol. 70, pp. 1170- 1176 ,(1982) , 10.1172/JCI110715